AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 22228231 — intervention group
Group type: EXPERIMENTAL
Intervention: RIX4414
Number of subjects: 1009
Study 22228231 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1009
Study 20160655 — intervention group
Group type: EXPERIMENTAL
Intervention: Music-guided slow breathing exercises (4-6 breaths/min; 1:2 ratio of inspiration: expiration duration)
Number of subjects: 86
Study 20160655 — intervention group
Group type: COMPARATOR
Intervention: Control-M (listening to slow music)
Number of subjects: 86
Study 20160655 — intervention group
Group type: COMPARATOR
Intervention: Control-R (reading a book)
Number of subjects: 86
Study 18515918 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide/formoterol (SMART)
Number of subjects: 3335
Study 18515918 — intervention group
Group type: COMPARATOR
Intervention: Fixed higher-dose budesonide/formoterol (FHDBF)
Number of subjects: 3335
Study 18515918 — intervention group
Group type: COMPARATOR
Intervention: Fixed dose fluticasone/salmeterol (FDFS)
Number of subjects: 3335
Study 16223399 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg of magnesium sulphate 5% (1.0 ml)
Number of subjects: 102
Study 16223399 — intervention group
Group type: COMPARATOR
Intervention: 1.0 ml of preservative‐free 0.9% sodium chloride
Number of subjects: 102
Study 12141771 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone propionate
Number of subjects: 12
Study 12141771 — intervention group
Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 12
Study 10208945 — intervention group
Group type: COMPARATOR
Intervention: 5 mg of salbutamol by jet nebuliser
Number of subjects: 61
Study 10208945 — intervention group
Group type: EXPERIMENTAL
Intervention: Up to 10 puffs of salbutamol 100 microg by metered dose inhaler and spacer
Number of subjects: 61
Study 8586752 — intervention group
Group type: EXPERIMENTAL
Intervention: Blend method (permanent hair removal)
Number of subjects: 14
Study 8586752 — intervention group
Group type: COMPARATOR
Intervention: Plucking (temporary hair removal)
Number of subjects: 14
Study 1693335 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose oral treatment
Number of subjects: 60
Study 1693335 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose oral treatment
Number of subjects: 60
Study 1693335 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous hyposensitization regime
Number of subjects: 60
Study 606781 — intervention group
Group type: EXPERIMENTAL
Intervention: Inactivated influenza A/New Jersey/X-53 subunit virus vaccine (100 or 200 CCA units for children ≤9 years; 200 or 400 CCA units for children >9 years), administered intramuscularly in two doses at intervals of four weeks.
Number of subjects: 103
Study 31046541 — intervention group
Group type: EXPERIMENTAL
Intervention: Omalizumab
Number of subjects: 21
Study 31046541 — intervention group
Group type: EXPERIMENTAL
Intervention: Mepolizumab
Number of subjects: 21
Study 31046541 — intervention group
Group type: EXPERIMENTAL
Intervention: Reslizumab
Number of subjects: 21
Study 31046541 — intervention group
Group type: EXPERIMENTAL
Intervention: Benralizumab
Number of subjects: 21
Study 31046541 — intervention group
Group type: EXPERIMENTAL
Intervention: Dupilumab
Number of subjects: 21
Study 31046541 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study 31078191 — intervention group
Group type: EXPERIMENTAL
Intervention: CCNP + RE
Number of subjects: 87
Study 31078191 — intervention group
Group type: COMPARATOR
Intervention: RE
Number of subjects: 87
Study 28796648 — intervention group
Group type: EXPERIMENTAL
Intervention: Slow robot-assisted locomotor training
Number of subjects: 18
Study 28796648 — intervention group
Group type: COMPARATOR
Intervention: Fast robot-assisted locomotor training
Number of subjects: 18
Study 26226884 — intervention group
Group type: EXPERIMENTAL
Intervention: Donepezil (3, 5, and 10 mg)
Number of subjects: 281
Study 26226884 — intervention group
Group type: EXPERIMENTAL
Intervention: Donepezil (5 and 10 mg)
Number of subjects: 281
Study 26226884 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 281
Study 23536583 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive glucose-lowering therapy (INT)
Number of subjects: 266
Study 21959068 — intervention group
Group type: EXPERIMENTAL
Intervention: Valerian (255 mg, 3 times daily for 3 days)
Number of subjects: 100
Study 21959068 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 21959068 — intervention group
Group type: EXPERIMENTAL
Intervention: Valerian
Number of subjects: 100
Study 18810398 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylene blue (MB) 500 mg orally
Number of subjects: 16
Study 18810398 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylene blue (MB) 500 mg orally combined with chloroquine (CQ) 750 mg
Number of subjects: 16
Study 18810398 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylene blue (MB) 50 mg intravenous (i.v.)
Number of subjects: 16
Study 18810398 — intervention group
Group type: COMPARATOR
Intervention: Chloroquine (CQ) 750 mg administered orally alone
Number of subjects: 16
Study 17971947 — intervention group
Group type: EXPERIMENTAL
Intervention: ADV 10 mg/d for 48 weeks
Number of subjects: 226
Study 17971947 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 24 weeks followed by ADV 10 mg/d for 24 weeks
Number of subjects: 226
Study 15512809 — intervention group
Group type: EXPERIMENTAL
Intervention: 500 mg valacyclovir orally every 8 h
Number of subjects: 81
Study 15512809 — intervention group
Group type: EXPERIMENTAL
Intervention: 1,000 mg valacyclovir orally every 8 h
Number of subjects: 81
Study 11368294 — intervention group
Group type: EXPERIMENTAL
Intervention: ZD1839 (1 to 75mg)
Number of subjects: 100
Study 11368294 — intervention group
Group type: EXPERIMENTAL
Intervention: ZD1839 (100mg once daily for 3 days)
Number of subjects: 100
Study 11368294 — intervention group
Group type: COMPARATOR
Intervention: Single 50mg dose of ZD1839 with food
Number of subjects: 100
Study 11368294 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 9487372 — intervention group
Group type: EXPERIMENTAL
Intervention: Single dose total-body irradiation (STBI) - 10 Gy to midplane, 8 Gy to lungs
Number of subjects: 326
Study 9487372 — intervention group
Group type: EXPERIMENTAL
Intervention: Fractionated total-body irradiation (FTBI) - 12 Gy on 3 consecutive days, 9 Gy to lungs
Number of subjects: 326
Study 9487372 — intervention group
Group type: EXPERIMENTAL
Intervention: LOW instantaneous dose rate group (< or = 0.048 Gy/min)
Number of subjects: 326
Study 9487372 — intervention group
Group type: EXPERIMENTAL
Intervention: MEDIUM instantaneous dose rate group (> 0.048 and < or = 0.09 Gy/min)
Number of subjects: 326
Study 9487372 — intervention group
Group type: EXPERIMENTAL
Intervention: HIGH instantaneous dose rate group (> 0.09 Gy/min)
Number of subjects: 326
Study 9487372 — intervention group
Group type: EXPERIMENTAL
Intervention: Allogeneic BMT
Number of subjects: 326
Study 9487372 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous BMT
Number of subjects: 326
Study 9487372 — intervention group
Group type: EXPERIMENTAL
Intervention: Graft-vs-host disease (GvHD)
Number of subjects: 326
Study 9487372 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment after 1985
Number of subjects: 326
Study 9487372 — intervention group
Group type: EXPERIMENTAL
Intervention: Cataract incidence influenced by instantaneous dose rate
Number of subjects: 326
Study 8306272 — intervention group
Group type: EXPERIMENTAL
Intervention: 131I-Mu-9 immunoglobulin G
Number of subjects: 25
Study 8306272 — intervention group
Group type: EXPERIMENTAL
Intervention: 131I-F(ab')2
Number of subjects: 25
Study 8306272 — intervention group
Group type: COMPARATOR
Intervention: Both 131I-Mu-9 immunoglobulin G and 131I-F(ab')2
Number of subjects: 25
Study 3178928 — intervention group
Group type: EXPERIMENTAL
Intervention: Maxepa (3.24 g eicosapentaenoic acid and 2.16 g docosahexaenoic acid per day)
Number of subjects: 25
Study 3178928 — intervention group
Group type: EXPERIMENTAL
Intervention: Maxepa
Number of subjects: 25
Study 3178928 — intervention group
Group type: COMPARATOR
Intervention: Safflower oil (control)
Number of subjects: 25
Study 824725 — intervention group
Group type: EXPERIMENTAL
Intervention: Diftalone 500 mg/day
Number of subjects: 30
Study 824725 — intervention group
Group type: COMPARATOR
Intervention: Indomethacin 50-75 mg/day initially and 100 mg/day subsequently
Number of subjects: 30
Study 31118245 — intervention group
Group type: EXPERIMENTAL
Intervention: Efgartigimod (10 mg/kg IV)
Number of subjects: 24
Study 31118245 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 28378467 — intervention group
Group type: EXPERIMENTAL
Intervention: Ephedrine (6 mg boluses)
Number of subjects: 0
Study 28378467 — intervention group
Group type: COMPARATOR
Intervention: Phenylephrine (50 μg boluses)
Number of subjects: 0
Study 26470910 — intervention group
Group type: EXPERIMENTAL
Intervention: Residents performing ≥50% of distal anastomoses in on-pump CABG
Number of subjects: 1272
Study 26470910 — intervention group
Group type: EXPERIMENTAL
Intervention: Residents performing ≥50% of distal anastomoses in off-pump CABG
Number of subjects: 1272
Study 26470910 — intervention group
Group type: COMPARATOR
Intervention: Attending surgeons performing distal anastomoses in on-pump CABG
Number of subjects: 1272
Study 26470910 — intervention group
Group type: COMPARATOR
Intervention: Attending surgeons performing distal anastomoses in off-pump CABG
Number of subjects: 1272
Study 24382638 — intervention group
Group type: EXPERIMENTAL
Intervention: Telaprevir (TVR) 750 mg q8h plus peginterferon (180 μg/week) and ribavirin (1,000-1,200 mg/day)
Number of subjects: 578
Study 24382638 — intervention group
Group type: COMPARATOR
Intervention: Peginterferon/ribavirin (PR48) alone
Number of subjects: 578
Study 21500996 — intervention group
Group type: EXPERIMENTAL
Intervention: Estroprogestagen therapy (EP)
Number of subjects: 78
Study 19719534 — intervention group
Group type: EXPERIMENTAL
Intervention: Active heat recovery ventilators (HRV)
Number of subjects: 68
Study 19719534 — intervention group
Group type: COMPARATOR
Intervention: Placebo heat recovery ventilators (HRV)
Number of subjects: 68
Study 17848814 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured physical training program
Number of subjects: 63
Study 17848814 — intervention group
Group type: COMPARATOR
Intervention: Standard complex rehabilitation program
Number of subjects: 63
Study 15612844 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone-based monitoring and brief counseling intervention (TEL)
Number of subjects: 359
Study 15612844 — intervention group
Group type: COMPARATOR
Intervention: Standard 12-step group counseling (STND)
Number of subjects: 359
Study 15612844 — intervention group
Group type: COMPARATOR
Intervention: Relapse prevention (RP)
Number of subjects: 359
Study 11734711 — intervention group
Group type: EXPERIMENTAL
Intervention: Serogroup B meningococcal vaccine VA‐MENGOC‐BC (2 doses)
Number of subjects: 105
Study 11734711 — intervention group
Group type: EXPERIMENTAL
Intervention: Serogroup B meningococcal vaccine VA‐MENGOC‐BC (3 doses)
Number of subjects: 105
Study 11734711 — intervention group
Group type: EXPERIMENTAL
Intervention: Serogroup B meningococcal vaccine VA‐MENGOC‐BC
Number of subjects: 105
Study 9403267 — intervention group
Group type: EXPERIMENTAL
Intervention: Povidone-iodine (PVP-I) ethanol solution
Number of subjects: 0
Study 9403267 — intervention group
Group type: COMPARATOR
Intervention: Chlorhexidine (CH) ethanol
Number of subjects: 0
Study 7959609 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance training program (12 weight-lifting exercises, 3 sets of 8 repetitions, 3 times per week)
Number of subjects: 14
Study 7959609 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention details provided)
Number of subjects: 14
Study 3300707 — intervention group
Group type: EXPERIMENTAL
Intervention: Gold-plated tympanostomy tubes
Number of subjects: 28
Study 3300707 — intervention group
Group type: COMPARATOR
Intervention: Teflon tympanostomy tubes
Number of subjects: 28
Study 31588833 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard-length CWMT (45 min/session, 25 sessions, n = 29)
Number of subjects: 89
Study 31588833 — intervention group
Group type: EXPERIMENTAL
Intervention: Shortened-length CWMT (15 min/session, 25 sessions, n = 32)
Number of subjects: 89
Study 31588833 — intervention group
Group type: COMPARATOR
Intervention: Waitlist group (n = 28)
Number of subjects: 89
Study 29868911 — intervention group
Group type: EXPERIMENTAL
Intervention: High-nitrate (HN) vegetables (∼200 g/d; ∼150 mg nitrate/d)
Number of subjects: 30
Study 29868911 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-nitrate (LN) vegetables (∼200 g/d; ∼22 mg nitrate/d)
Number of subjects: 30
Study 29868911 — intervention group
Group type: COMPARATOR
Intervention: Control (no increase in vegetables; ∼6 mg nitrate/d)
Number of subjects: 30
Study 26940938 — intervention group
Group type: EXPERIMENTAL
Intervention: Trametinib 2 mg once daily
Number of subjects: 493
Study 24565357 — intervention group
Group type: EXPERIMENTAL
Intervention: CBT
Number of subjects: 488
Study 24565357 — intervention group
Group type: EXPERIMENTAL
Intervention: SRT
Number of subjects: 488
Study 24565357 — intervention group
Group type: EXPERIMENTAL
Intervention: COMB
Number of subjects: 488
Study 24565357 — intervention group
Group type: COMPARATOR
Intervention: PBO
Number of subjects: 488
Study 23553866 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.5 mg fluoride
Number of subjects: 180
Study 23553866 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg fluoride
Number of subjects: 180
Study 23553866 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg fluoride
Number of subjects: 180
Study 23553866 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 180
Study 19682880 — intervention group
Group type: EXPERIMENTAL
Intervention: Escin (60mg daily, 30mg every 12 hours for 2 months)
Number of subjects: 219
Study 19682880 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery
Number of subjects: 219
Study 19682880 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 219
Study 19682880 — intervention group
Group type: EXPERIMENTAL
Intervention: Escin
Number of subjects: 219
Study 17559717 — intervention group
Group type: EXPERIMENTAL
Intervention: Inducing rumination
Number of subjects: 81
Study 17559717 — intervention group
Group type: EXPERIMENTAL
Intervention: Inducing distraction
Number of subjects: 81
Study 17559717 — intervention group
Group type: EXPERIMENTAL
Intervention: Rumination and stress interaction
Number of subjects: 81
Study 17559717 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative attentional bias
Number of subjects: 81
Study 15826880 — intervention group
Group type: EXPERIMENTAL
Intervention: Folic acid supplementation (5 mg daily, n = 36)
Number of subjects: 74
Study 15826880 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 38)
Number of subjects: 74
Study 12812355 — intervention group
Group type: EXPERIMENTAL
Intervention: Mefloquine (MQ) 15 mg/kg in a single oral dose
Number of subjects: 98
Study 12812355 — intervention group
Group type: EXPERIMENTAL
Intervention: Mefloquine-artesunate (MQ-AS) combination therapy (MQ 15 mg/kg plus AS 4 mg/kg/day for three days)
Number of subjects: 98
Study 15536661 — intervention group
Group type: EXPERIMENTAL
Intervention: Saint GERVAIS water application
Number of subjects: 0
Study 15536661 — intervention group
Group type: COMPARATOR
Intervention: Bidistilled water
Number of subjects: 0
Study 10451079 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer assisted educational intervention about appropriate utilization of Arthrotec (diclofenac + misoprostol)
Number of subjects: 252
Study 10451079 — intervention group
Group type: COMPARATOR
Intervention: Generic information about OA (control condition)
Number of subjects: 252
Study 7786658 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin 50 mg
Number of subjects: 12
Study 7786658 — intervention group
Group type: EXPERIMENTAL
Intervention: Prostaglandin E2 infusion
Number of subjects: 12
Study 7786658 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril
Number of subjects: 12
Study 2241595 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranitidine 150 mg bid
Number of subjects: 190
Study 2241595 — intervention group
Group type: COMPARATOR
Intervention: Ranitidine 300 mg nocte
Number of subjects: 190
Study 738065 — intervention group
Group type: EXPERIMENTAL
Intervention: Left visual field (LVF) presentation of faces
Number of subjects: 80
Study 738065 — intervention group
Group type: COMPARATOR
Intervention: Right visual field (RVF) presentation of faces
Number of subjects: 80
Study 738065 — intervention group
Group type: COMPARATOR
Intervention: Left visual field (LVF) presentation of letter pairs
Number of subjects: 80
Study 738065 — intervention group
Group type: COMPARATOR
Intervention: Right visual field (RVF) presentation of letter pairs
Number of subjects: 80
Study 738065 — intervention group
Group type: EXPERIMENTAL
Intervention: 7-year-old group with LVF presentation of faces
Number of subjects: 80
Study 738065 — intervention group
Group type: COMPARATOR
Intervention: 7-year-old group with RVF presentation of letter pairs
Number of subjects: 80
Study 28917242 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive school-based intervention
Number of subjects: 9867
Study 28917242 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 9867
Study 25977929 — intervention group
Group type: EXPERIMENTAL
Intervention: High maternal BMI
Number of subjects: 2305
Study 25977929 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal height
Number of subjects: 2305
Study 25977929 — intervention group
Group type: EXPERIMENTAL
Intervention: Antidepressant use
Number of subjects: 2305
Study 25977929 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregnancy weight-gain exceeding 40 pounds
Number of subjects: 2305
Study 25977929 — intervention group
Group type: EXPERIMENTAL
Intervention: High blood sugar
Number of subjects: 2305
Study 25977929 — intervention group
Group type: COMPARATOR
Intervention: Diagnosed and treated gestational diabetes
Number of subjects: 2305
Study 25977929 — intervention group
Group type: EXPERIMENTAL
Intervention: Single abnormal glucose tolerance test (no diagnosis of gestational diabetes)
Number of subjects: 2305
Study 25977929 — intervention group
Group type: EXPERIMENTAL
Intervention: BMI and pregnancy weight-gain
Number of subjects: 2305
Study 22889696 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV/AIDS educational intervention
Number of subjects: 90
Study 22889696 — intervention group
Group type: COMPARATOR
Intervention: Sham intervention
Number of subjects: 90
Study 21699364 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrogel dressing
Number of subjects: 15
Study 21699364 — intervention group
Group type: COMPARATOR
Intervention: Vaseline® cream (placebo)
Number of subjects: 15
Study 19188505 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention (PCI)
Number of subjects: 300
Study 19188505 — intervention group
Group type: COMPARATOR
Intervention: Optimal medical therapy
Number of subjects: 300
Study 16904540 — intervention group
Group type: EXPERIMENTAL
Intervention: Sinus Rhythm (SR)
Number of subjects: 624
Study 15005829 — intervention group
Group type: EXPERIMENTAL
Intervention: Green tea (caffeine 104 mg/d, catechins 573 mg/d, 323 mg epigallocatechin gallate)
Number of subjects: 104
Study 15005829 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 104
Study 15005829 — intervention group
Group type: EXPERIMENTAL
Intervention: Green tea (with high caffeine consumption)
Number of subjects: 104
Study 15005829 — intervention group
Group type: EXPERIMENTAL
Intervention: Green tea (with low caffeine consumption)
Number of subjects: 104
Study 11737400 — intervention group
Group type: EXPERIMENTAL
Intervention: HAART plus interleukin-2 (IL-2) and hydroxyurea
Number of subjects: 22
Study 11737400 — intervention group
Group type: COMPARATOR
Intervention: HAART only
Number of subjects: 22
Study 9094924 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional status assessment through height and weight measurement
Number of subjects: 0
Study 9094924 — intervention group
Group type: EXPERIMENTAL
Intervention: Food intake assessment through two 24-h recalls
Number of subjects: 0
Study 9094924 — intervention group
Group type: EXPERIMENTAL
Intervention: Assessment of nutrient intakes
Number of subjects: 0
Study 8216453 — intervention group
Group type: EXPERIMENTAL
Intervention: Gel formulation (Iprogel)
Number of subjects: 6
Study 8216453 — intervention group
Group type: COMPARATOR
Intervention: Hydrophilic ointment
Number of subjects: 6
Study 8216453 — intervention group
Group type: COMPARATOR
Intervention: Emulsion cream (reference product)
Number of subjects: 6
Study 29940521 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended Clinical Management (E-CM)
Number of subjects: 177
Study 29940521 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychoeducational Cognitive Behavioural Group Therapy (PCBT-G)
Number of subjects: 177
Study 29940521 — intervention group
Group type: EXPERIMENTAL
Intervention: PCBT-G plus 16 outpatient individual treatment sessions (PCBT-G+I)
Number of subjects: 177
Study 29940521 — intervention group
Group type: COMPARATOR
Intervention: PCBT-G and PCBT-G+I
Number of subjects: 177
Study 29940521 — intervention group
Group type: COMPARATOR
Intervention: PCBT-G+I
Number of subjects: 177
Study 29940521 — intervention group
Group type: COMPARATOR
Intervention: PCBT-G
Number of subjects: 177
Study 27136509 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold water immersion (8.9±0.6°C; 9 min with 1 min out of water, repeated twice)
Number of subjects: 8
Study 27136509 — intervention group
Group type: COMPARATOR
Intervention: Control (players remained seated for 20 min)
Number of subjects: 8
Study 27136509 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold water immersion
Number of subjects: 8
Study 27136509 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 8
Study 24452826 — intervention group
Group type: EXPERIMENTAL
Intervention: Removable dental prostheses (RDP)
Number of subjects: 152
Study 24452826 — intervention group
Group type: COMPARATOR
Intervention: Shortened dental arches (SDA)
Number of subjects: 152
Study 22634125 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical resection (RES)
Number of subjects: 168
Study 22634125 — intervention group
Group type: COMPARATOR
Intervention: Radiofrequency ablation (RFA)
Number of subjects: 168
Study 20456065 — intervention group
Group type: EXPERIMENTAL
Intervention: Desflurane
Number of subjects: 400
Study 20456065 — intervention group
Group type: COMPARATOR
Intervention: Isoflurane
Number of subjects: 400
Study 20456065 — intervention group
Group type: EXPERIMENTAL
Intervention: Desflurane (deep anesthesia removal)
Number of subjects: 400